Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy | Science
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy | Science
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy | Science
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page